An Investigation of the Pharmacokinetics of GSK961081 and Fluticasone Propionate in Healthy Volunteers

NCT01449799 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: GSK961081 800 microgram dose
DRUG: Fluticasone Propionate 500 microgram dose
DRUG: GSK961081 800 microgram and Fluticasone Propionate 500 microgram separately
DRUG: GSK961081 800 microgram Fluticasone Propionate 500 microgram in a blend

Sponsor

GlaxoSmithKline